FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On November 5, 2003
Table of Contents
Docket # Title
1978N-0036L OTC Laxative
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
2003D-0380 Draft Guidance for Industry: PAT - A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance; Availability
2003D-0382 Draft Guidance: Sterile Drug Products Produced by Aseptic Processing
2003D-0383 Draft Guidance for Industry and FDA Staff; Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use; Availability
2003D-0478 Guidance on Marketed Unapproved Drugs Compliance Policy Guide
2003M-0487 P020007 - Medtronic AVE Bridge Extra Support Over-the-Wire (OTW) Renal Stent System
2003M-0488 P020041- FemCap Barrier Contraceptive
2003M-0490 P030009 - Medtronic Vascular Driver Over-the-Wire, Rapid Exchange, and Multi-Exchange Coronary Stent Systems
2003M-0491 P020050 - WaveLight ALLEGRETTO WAVE Excimer Laser System
2003M-0492 P030008 - WaveLight ALLEGRETTO WAVE Excimer Laser System
2003M-0499 P020047 - MULTI-LINK RX and OTW VISION Coronary Stent Systems
2003N-0361 Anti-Counterfeit Drug Initiative
2003N-0400 Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
2003P-0517 Determine that Pennifield is not now, and never has been eligible for interim marketing for bacitracin MD
2003P-0518 Refrain from approving any Abbreviated New Drug Application for sirolimus with Rapamune (sirolimus)
2003V-0510 Laser Light Show
2003V-0514 Laser Light Show
2003V-0515 Laser Display Device
2003V-0516 Laser Light Show
1978N-0036L OTC Laxative
C 206
Tab 1, 2, 3, 4, 5
Madaus AG (Madaus) Vol #: 121
LET 202 The Purdue Frederick Company (Purdue) Vol #: 121
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 11465 Evolution-X Vol #: 89
LET 11466 Herbo, Inc. Vol #: 89
LET 11467 Herbo, Inc. Vol #: 89
LET 11468 Herbo, Inc. Vol #: 89
LET 11469 Herbo, Inc. Vol #: 89
LET 11470 Herbo, Inc. Vol #: 89
LET 11471 Herbo, Inc. Vol #: 89
LET 11472 Herbo, Inc. Vol #: 89
LET 11473 Herbo, Inc. Vol #: 89
LET 11474 Herbo, Inc. Vol #: 89
LET 11475 Herbo, Inc. Vol #: 89
LET 11476 Herbo, Inc. Vol #: 89
LET 11477 Herbo, Inc. Vol #: 89
LET 11478 Herbo, Inc. Vol #: 89
LET 11479 Herbo, Inc. Vol #: 89
LET 11480 Herbo, Inc. Vol #: 89
LET 11481 Herbo, Inc. Vol #: 89
LET 11482 Solgar Vitamin & Herbs Vol #: 89
LET 11483 Recovery Pharmaceuticals, Inc. Vol #: 89
LET 11484 Perrigo Company of South Carolina Vol #: 89
LET 11485 Natrol, Inc. Vol #: 89
LET 11486 Perrigo Company of South Carolina Vol #: 89
2003D-0380 Draft Guidance for Industry: PAT - A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance; Availability
EMC 2 Facility Automation Management Engineering Systems Vol #: 1
EMC 3
Attachment
H. Lundbeck A/S Vol #: 1
EMC 4 Eli Lilly and Company Vol #: 1
EMC 5 Pfizer, Inc. Vol #: 1
EMC 6 GlaxoSmithKline Vol #: 1
2003D-0382 Draft Guidance: Sterile Drug Products Produced by Aseptic Processing
EMC 9
Enclosure
European Federation of Pharmaceutical Industries and Associations (EFPIA) Vol #: 2
EMC 10
Enclosure
European Federation of Pharmaceutical Industries and Associations (EFPIA) Vol #: 2
EMC 11 Pfizer, Inc. Vol #: 2
EMC 12 Skan AG Vol #: 2
EMC 13 Robert BOSCH GmbH Vol #: 2
EMC 14
Attachment
Aventis Behring Vol #: 2
EMC 15 GlaxoSmithKline Vol #: 2
EMC 16 B. Braun Medical, Inc. Vol #: 2
EMC 17
Attachment
International Assn for Pharmaceutical Science and Technology (PDA) Vol #: 2
EMC 18 Parenteral Society Vol #: 2
EMC 19 Parenteral Society Vol #: 2
2003D-0383 Draft Guidance for Industry and FDA Staff; Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use; Availability
EMC 1 Future Diagnostics B.V. Vol #: 1
2003D-0478 Guidance on Marketed Unapproved Drugs Compliance Policy Guide
EMC 9 Winston Wiley Vol #: 1
EMC 10 Sunil Shah Vol #: 1
2003M-0487 P020007 - Medtronic AVE Bridge Extra Support Over-the-Wire (OTW) Renal Stent System
AAV 1
Approval order, SSED, Labelling
Medtronic AVE, Inc. Vol #: 1
2003M-0488 P020041- FemCap Barrier Contraceptive
AAV 1
Approval order, SSED, Labelling
FemCap, Inc. Vol #: 1
2003M-0490 P030009 - Medtronic Vascular Driver Over-the-Wire, Rapid Exchange, and Multi-Exchange Coronary Stent Systems
AAV 1
Approval order, SSED, Labelling
Medtornic Vascular Vol #: 1
2003M-0491 P020050 - WaveLight ALLEGRETTO WAVE Excimer Laser System
AAV 1
Approval order, SSED, Labelling
Surgi-Vision Refractive Consultants, LLC Vol #: 1
2003M-0492 P030008 - WaveLight ALLEGRETTO WAVE Excimer Laser System
AAV 1
Approval order, SSED, Labelling
Surgi-Vision Refractive Consultants, LLC Vol #: 1
2003M-0499 P020047 - MULTI-LINK RX and OTW VISION Coronary Stent Systems
AAV 1
Approval order, SSED, Labelling
Guidant Corporation Vol #: 1
2003N-0361 Anti-Counterfeit Drug Initiative
EMC 8 M Cappuccio Vol #: 4
EMC 9 Academy of Managed Care Pharmacy (AMCP) Vol #: 4
EMC 10
Attachment 1, 2, 3, 4
Kezzler AS Vol #: 4
EMC 11 TSSI Vol #: 4
EMC 12
Attachment 1, 2
Uniform Code Council, Inc. (UCC) Vol #: 4
EMC 13
Attachment 1, 2
Uniform Code Council, Inc. (UCC) Vol #: 4
EMC 14 Tracer Detection Technology Corp. Vol #: 4
EMC 15 Number not Used Vol #: 4
EMC 16 West Pharmaceutical Services, Inc. Vol #: 4
EMC 17 American Medical Assn (AMA) Vol #: 4
EMC 18 GlaxoSmithKline Vol #: 4
EMC 19 Biotechnology Industry Organization (BIO) Vol #: 4
EMC 20 National Assn of Chain Drug Stores (NACDS) Vol #: 4
EMC 21 Amgen Inc. (Amgen) Vol #: 4
EMC 22 Merck & Co., Inc. Vol #: 4
EMC 23 Anda, Inc. Vol #: 4
EMC 24 NNC Group, LLC Vol #: 4
EMC 25
Attachment 1, 2
Sun Microsystems, Inc. (Sun) Vol #: 4
EMC 26 Number Not Used Vol #: 4
EMC 27 American Pharmacists Assn (APhA) Vol #: 4
EMC 28 McKesson Corporation (McKesson) Vol #: 4
EMC 29
Attachment 1, 2, 3
Zebra Technologies Corporation Vol #: 4
EMC 30 FFF Enterprises (FFF) Vol #: 4
2003N-0400 Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
EMC 1 Thomas G. Crouthamel, Sr. Vol #: 1
2003P-0517 Determine that Pennifield is not now, and never has been eligible for interim marketing for bacitracin MD
ACK 1 HFA-305 to Alpharma Inc. Vol #: 1
CP 1
Tab 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Alpharma Inc. Vol #: 1
2003P-0518 Refrain from approving any Abbreviated New Drug Application for sirolimus with Rapamune (sirolimus)
ACK 1 HFA-305 to Wyeth Pharmaceuticals Vol #: 1
CP 1 Wyeth Pharmaceuticals Vol #: 1
2003V-0510 Laser Light Show
ACK 1 HFA-305 to InterVision Vol #: 1
2003V-0514 Laser Light Show
ACK 1 HFA-305 to Heritage Planetarium Vol #: 1
VAR 1 Heritage Planetarium Vol #: 1
2003V-0515 Laser Display Device
ACK 1 HFA-305 to Full House Productions L. L. C. Vol #: 1
VAR 1 Full House Productions L. L. C. Vol #: 1
2003V-0516 Laser Light Show
VAR 1 Vanderbilt Museum Planetarium Vol #: 1

Page created on November 6, 2003 kk
Page updated on December 5, 2003 jb

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management